MiR-20b, -21, and -130b inhibit PTEN expression resulting in B7-H1 over-expression in advanced colorectal cancer

Area of Science:

• Oncology
• Immunology
• Molecular Biology

Background:

• B7-H1 (Programmed Death-Ligand 1) is a key immune checkpoint protein overexpressed in many cancers, contributing to immune evasion by inhibiting T cell responses.
• The precise molecular mechanisms driving B7-H1 overexpression in cancer, particularly colorectal cancer, are not fully understood.
• PTEN (Phosphatase and Tensin homolog) is a tumor suppressor protein often downregulated in cancer.

Purpose of the Study:

• To investigate the relationship between B7-H1 and PTEN expression in colorectal cancer.
• To identify microRNAs (miRNAs) that may regulate PTEN expression in colorectal cancer.
• To elucidate the role of specific miRNAs in the B7-H1/PTEN pathway in colorectal cancer progression.

Main Methods:

• Immunohistochemistry was used to detect B7-H1 and PTEN protein expression in colorectal cancer and normal tissues.
• MicroRNA array analysis was performed on colorectal cancer and adjacent normal tissues to identify differentially expressed miRNAs.
• Dual-luciferase reporter assays were employed to validate the regulatory effect of identified miRNAs on PTEN expression.

Main Results:

• B7-H1 expression was detected in 54.5% of colorectal cancer tissues, while PTEN expression was reduced in cancer tissues compared to normal tissues.
• A significant negative correlation was observed between B7-H1 and PTEN expression levels in colorectal cancer (p=0.001).
• Three miRNAs (miR-20b, miR-21, and miR-130b) were found to be upregulated in colorectal cancer tissues and were confirmed to suppress PTEN expression.

Conclusions:

• Upregulated miR-20b, miR-21, and miR-130b in colorectal cancer inhibit PTEN expression.
• This inhibition of PTEN leads to the subsequent overexpression of B7-H1.
• The identified miRNA-PTEN-B7-H1 axis represents a novel mechanism contributing to immune evasion in colorectal cancer.